NewsBenzingaUtah Medical Products : BPA du T3 à 0,88 $ contre 0,82 $ un an plus tôt, chiffre d’affaires à 8,621 M$ contre 9,812 M$ un an plus tôt Utah Medical Products : BPA du T3 à 0,88 $ contre 0,82 $ un an plus tôt, chiffre d’affaires à 8,621 M$ contre 9,812 M$ un an plus tôt Benzinga 2026.10.22 13:09 (GMT+0) Open on Benzinga Other news LDP: The Family Favorite But Not Enough (NYSE:LDP) Betterware: Tupperware Looks Better, But Jafra Looks Worse (NYSE:BWMX) Palo Alto CEO Nikesh Arora Warns Companies to Assume They Will Get ‘Breached’ and Fix Their ‘Technology Debt’ as AI Uncovers Critical Software Flaws Tower Semiconductor: The Silicon Photonics Opportunity Is Taking Shape (NASDAQ:TSEM) Enovis Screens Cheap, But There Is A Continued M&A Overhang (NYSE:ENOV) Coeur Mining: The Cost Trick Every Silver Investor Should Understand (NYSE:CDE)
Palo Alto CEO Nikesh Arora Warns Companies to Assume They Will Get ‘Breached’ and Fix Their ‘Technology Debt’ as AI Uncovers Critical Software Flaws
